Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

WILLIAM ABRAMOVITS

Allopathic & Osteopathic Physicians Dermatology

NPI
1154379188
CMS profile
233124
Location
DALLAS, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$122,501.48

322 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

By paying entity

PY2019 · entire year · sorted by reported total

Page 2 of 7; records 51–100 of 322 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

WILLIAM ABRAMOVITS

NPI 1154379188 · CMS profile ID 233124

Allopathic & Osteopathic Physicians / Dermatology

DALLAS, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 7; records 51–100 of 322 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1154379188?year=2019&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
WILLIAM ABRAMOVITS, NPI 1154379188, CMS profile ID 233124. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 7; records 51–100 of 322 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1154379188?year=2019&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). WILLIAM ABRAMOVITS, NPI 1154379188, CMS profile ID 233124. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 7; records 51–100 of 322 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1154379188?year=2019&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
WILLIAM ABRAMOVITS, NPI 1154379188, CMS profile ID 233124, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 7; records 51–100 of 322 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1154379188?year=2019&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

322 matching records · $122,501.48 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 322 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 322.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Janssen Biotech, Inc. $12.9310/29/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658291685 CMS
UCB, Inc. $15.6610/28/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 688244271 CMS
UCB, Inc. $4,200.0010/28/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 688244273 CMS
Novartis Pharmaceuticals Corporation $27.5010/24/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659194647 CMS
Janssen Biotech, Inc. $8.6610/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658291679 CMS
Janssen Biotech, Inc. $22.7910/21/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658291675 CMS
Galderma Laboratories, L.P. $10.1910/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 687659037 CMS
UCB, Inc. $25.0110/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 688243951 CMS
UCB, Inc. $24.9910/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 688243953 CMS
UCB, Inc. $24.9910/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 688243955 CMS
UCB, Inc. $292.6710/18/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 688243957 CMS
UCB, Inc. $50.0010/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 688243959 CMS
UCB, Inc. $50.0010/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 688243961 CMS
Sun Pharmaceutical Industries Inc. $24.2710/17/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 704599287 CMS
Janssen Biotech, Inc. $6.6010/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658291673 CMS
LEO Pharma Inc. $22.2910/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 687252729 CMS
GENZYME CORPORATION $19.9610/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694171707 CMS
Janssen Biotech, Inc. $2.2910/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658291669 CMS
Almirall LLC $2.9810/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 676646201 CMS
Sebela Pharmaceuticals Inc. $14.9910/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 703869259 CMS
Ortho Dermatologics, a division of Bausch Health US, LLC $2,400.0010/10/2019 Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 684565025 CMS
Sun Pharmaceutical Industries Inc. $58.8610/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 704599285 CMS
UCB, Inc. $6.4210/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 688306625 CMS
AbbVie, Inc. $16.5610/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 647834937 CMS
Janssen Biotech, Inc. $4.0010/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658291665 CMS
Sun Pharmaceutical Industries Inc. $14.2810/04/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 704599347 CMS
Sun Pharmaceutical Industries Inc. $24.9010/02/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 704599283 CMS
Celgene Corporation $21.4310/01/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672956189 CMS
Celgene Corporation $117.3710/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672973963 CMS
Celgene Corporation $4,050.0010/01/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672984351 CMS
Novartis Pharmaceuticals Corporation $15.6309/30/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659194633 CMS
PFIZER INC. $13.3309/30/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672802293 CMS
Regeneron Healthcare Solutions, Inc. $8.0009/30/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673321549 CMS
Regeneron Healthcare Solutions, Inc. $11.6009/30/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673321553 CMS
Regeneron Healthcare Solutions, Inc. $2.0009/30/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673321557 CMS
Novartis Pharmaceuticals Corporation $265.0709/28/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659194655 CMS
Novartis Pharmaceuticals Corporation $1,750.0009/28/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659194659 CMS
Novartis Pharmaceuticals Corporation $130.0009/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659194663 CMS
Novartis Pharmaceuticals Corporation $379.0009/27/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659194621 CMS
Celgene Corporation $33.2009/26/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672970037 CMS
Celgene Corporation $4,050.0009/26/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672972695 CMS
Celgene Corporation $124.4509/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672986903 CMS
Janssen Biotech, Inc. $21.2809/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658291659 CMS
Janssen Biotech, Inc. $21.2809/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658291661 CMS
Regeneron Healthcare Solutions, Inc. $3,522.7509/25/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673321546 CMS
Celgene Corporation $5.5209/24/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672921725 CMS
Ortho Dermatologics, a division of Bausch Health US, LLC $37.2009/24/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 684565021 CMS
Ortho Dermatologics, a division of Bausch Health US, LLC $100.0009/24/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 684565023 CMS
Ortho Dermatologics, a division of Bausch Health US, LLC $142.2309/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 684565019 CMS
Regeneron Healthcare Solutions, Inc. $115.2609/20/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673321543 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $122,501.48 322
PY2020 $34,092.78 179
PY2021 $52,598.58 193
PY2022 $44,383.39 235
PY2023 $42,012.36 201
PY2024 $13,668.86 182
PY2025 $16,009.18 230

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $274,519.25 22
PY2024 Recipient $4,119.13 30
PY2024 Principal investigator $52,801.55 11
PY2023 Principal investigator $58,429.46 15
PY2022 Principal investigator $161,383.87 72
PY2021 Recipient $632.89 1
PY2021 Principal investigator $134,165.74 39
PY2020 Recipient $5.00 1
PY2020 Principal investigator $424,213.53 67
PY2019 Recipient $30,888.42 5
PY2019 Principal investigator $398,338.42 72

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

22 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $1,147.05 12/31/2025 Non-covered Recipient Entity
REVEAL RESEARCH INSTITUTE PLLC
A Phase 3 randomized, placebo-controlled, double-blind program to evaluate efficacy and safety of upadacitinib in adult and adolescent subjects with severe alopecia areata No dispute reported 06/30/2026 1202533485
Principal investigator 1 ABBVIE INC. $14,996.70 12/04/2025 Non-covered Recipient Entity
REVEAL RESEARCH INSTITUTE PLLC
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa No dispute reported 06/30/2026 1202526536
Principal investigator 1 ABBVIE INC. $31,610.55 11/05/2025 Non-covered Recipient Entity
REVEAL RESEARCH INSTITUTE PLLC
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa No dispute reported 06/30/2026 1202522607
Principal investigator 1 UCB SA $3,109.00 10/27/2025 Non-covered Recipient Entity
REVEAL RESEARCH INSTITUTE PLLC
A MULTICENTER, RANDOMIZED, PARALLEL-GROUP, DOUBLE-BLIND, ACTIVE-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF BIMEKIZUMAB COMPARED TO USTEKINUMAB IN CHILDREN AND ADOLESCENTS FROM 6 YEARS TO LESS THAN 18 YEARS OF AGE WITH MODERATE TO SEVERE PLAQUE PSORIASIS No dispute reported 06/30/2026 1246658040
Principal investigator 1 ABBVIE INC. $51,734.25 10/09/2025 Non-covered Recipient Entity
REVEAL RESEARCH INSTITUTE PLLC
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa No dispute reported 06/30/2026 1202514233
Principal investigator 1 Hoffmann-La Roche Limited $1,507.00 10/02/2025 Non-covered Recipient Entity
Reveal Research Institute
VELARITE No dispute reported 06/30/2026 1211647362
Principal investigator 1 Hoffmann-La Roche Limited $1,656.00 10/02/2025 Non-covered Recipient Entity
Reveal Research Institute
VELARITE No dispute reported 06/30/2026 1211647368
Principal investigator 1 Hoffmann-La Roche Limited $848.00 10/02/2025 Non-covered Recipient Entity
Reveal Research Institute
VELARITE No dispute reported 06/30/2026 1211647373
Principal investigator 1 Hoffmann-La Roche Limited $2,369.00 09/04/2025 Non-covered Recipient Entity
Reveal Research Institute
VELARITE No dispute reported 06/30/2026 1211647354
Principal investigator 1 Hoffmann-La Roche Limited $1,971.00 09/04/2025 Non-covered Recipient Entity
Reveal Research Institute
VELARITE No dispute reported 06/30/2026 1211647358
Principal investigator 1 ABBVIE INC. $32,263.35 07/02/2025 Non-covered Recipient Entity
REVEAL RESEARCH INSTITUTE PLLC
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa No dispute reported 06/30/2026 1202495005
Principal investigator 1 ABBVIE INC. $5,160.00 06/03/2025 Non-covered Recipient Entity
REVEAL RESEARCH INSTITUTE PLLC
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa No dispute reported 06/30/2026 1202488603
Principal investigator 1 ABBVIE INC. $26,836.95 05/07/2025 Non-covered Recipient Entity
REVEAL RESEARCH INSTITUTE PLLC
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa No dispute reported 06/30/2026 1202482777
Principal investigator 1 CSL Behring $1,223.00 04/09/2025 Non-covered Recipient Entity
Reveal Research Institute
A Phase 1, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics and Safety of Subcutaneous CSL324 in Healthy Japanese and White Subjects No dispute reported 06/30/2026 1252669194
Principal investigator 1 CSL Behring $8,000.00 04/09/2025 Non-covered Recipient Entity
Reveal Research Institute
A Phase 1, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics and Safety of Subcutaneous CSL324 in Healthy Japanese and White Subjects No dispute reported 06/30/2026 1252669196
Principal investigator 1 ABBVIE INC. $26,673.00 04/03/2025 Non-covered Recipient Entity
REVEAL RESEARCH INSTITUTE PLLC
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa No dispute reported 06/30/2026 1202471882
Principal investigator 1 ABBVIE INC. $24,288.00 03/07/2025 Non-covered Recipient Entity
REVEAL RESEARCH INSTITUTE PLLC
M20-465 - A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa No dispute reported 06/30/2026 1202459211
Principal investigator 1 ABBVIE INC. $2,855.25 03/07/2025 Non-covered Recipient Entity
REVEAL RESEARCH INSTITUTE PLLC
M23-716 - A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata (Up-AA) No dispute reported 06/30/2026 1202459261
Principal investigator 1 ABBVIE INC. $6,957.70 03/03/2025 Non-covered Recipient Entity
REVEAL RESEARCH INSTITUTE PLLC
M23-716 - A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata (Up-AA) No dispute reported 06/30/2026 1202455381
Principal investigator 1 ABBVIE INC. $21,986.10 02/06/2025 Non-covered Recipient Entity
REVEAL RESEARCH INSTITUTE PLLC
M20-465 - A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa No dispute reported 06/30/2026 1202448283
Principal investigator 1 ABBVIE INC. $4,638.15 01/02/2025 Non-covered Recipient Entity
REVEAL RESEARCH INSTITUTE PLLC
M20-465 - A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa No dispute reported 06/30/2026 1202435395
Principal investigator 1 ABBVIE INC. $2,689.20 01/01/2025 Non-covered Recipient Entity
REVEAL RESEARCH INSTITUTE PLLC
M23-716 - A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata (Up-AA) No dispute reported 06/30/2026 1202433330